Correlation Between the DEPDC5 Rs1012068 Polymorphism and the Risk of HBV-related Hepatocellular Carcinoma.

Wenxuan Liu,Ning Ma,Dongqiang Zhao,Xia Gao,Xiaolin Zhang,Lei Yang,Dianwu Liu
DOI: https://doi.org/10.1016/j.clinre.2018.12.005
IF: 3.189
2019-01-01
Clinics and Research in Hepatology and Gastroenterology
Abstract:Introduction: HBV and/or HCV infection is the main cause of hepatocellular carcinoma (HCC), but the molecular mechanisms by which HBV promotes HCC are not clear. In 2011, the result of a GWAS revealed a common variant of DEPDC5 affected HCC susceptibility in patient with chronic HCV infection in Japan. This study investigated the correlation between DEPDC5 polymorphism and HBV-related HCC. Materials and methods: 1289 samples of Han population were involved in northern China and peripheral blood samples were obtained, including 506 healthy controls, 217 Hepatitis B chronic (CHB) and 258 liver cirrhosis (LC), and 308 HBV-related HCC patients. SNPs in the DEPDC5 rs1012068 were detected by MALDI-TOF-MS. Results: After controlling for the influence of sex, smoking and drinking, this study showed a significant relationship between the polymorphism of DEPDC5 rs1012068 and HBV-related HCC. Healthy participants with CC genotype showed 2.008 (95% CI = 1.145, 3.520; P = 0.015) times more likely to develop HCC; CHB cases with CC genotype showed 2.241 (95% CI = 1.226, 4.461; P = 0.022) times more likely to develop HCC; LC cases with CC genotype showed 2.706 (95% CI = 1.371, 5.340; P = 0.004) times more likely to develop HCC; and individuals with AC genotype showed 1.615 (95% CI = 1.110, 2.352; P = 0.012) times more likely to develop HCC. Conclusions: There was a significant correlation between DEPDC5 rs1012068A/C and HBVrelated HCC in the Han Chinese population. A to C mutation increased the risk of the developing of HBV-related HCC. (C) 2019 Elsevier Masson SAS. All rights reserved.
What problem does this paper attempt to address?